ProCE Banner Activity

Managing AEs With Oral SERDs for Patients With HR+/HER2- Metastatic Breast Cancer

Slideset

Download these slides from a live satellite symposium at the San Antonio Breast Cancer Symposium covering strategies for the management of oral SERD-related AEs in patients with HR-positive/HER2-negative metastatic breast cancer.

Released: November 15, 2024

Expiration: November 14, 2025

Course Fee

$4.00

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grants from AstraZeneca and Lilly

AstraZeneca

Lilly